Equasens SA

Paris Stock Exchange EQS.PA

Equasens SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -17.76 M

Equasens SA Net Cash Used Provided By Financing Activities is USD -17.76 M for the year ending December 31, 2023, a 56.64% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Equasens SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD -40.95 M, a -267.17% change year over year.
Equasens SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -11.15 M, a -423.97% change year over year.
Equasens SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD 3.44 M, a 115.38% change year over year.
Equasens SA Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -22.38 M, a -397.39% change year over year.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

Paris Stock Exchange: EQS.PA

Equasens SA

CEO	Mr. Grégoire De Rotalier
IPO Date	Oct. 25, 2000
Location	France
Headquarters	5 AllEe de Saint Cloud
Employees	1,271
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Pharmaceuticals Software-as-a-Service (SaaS) Telehealth

Description

Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.

Key trends

Past 5 years